Ethanolamine-based lipid biosynthetic compounds, method of making and use thereof

Abstract

A method for treating cancer is disclosed. The method comprises administering to a subject in need thereof, an effective amount of a pharmaceutical composition comprising monoethanolamine, its prodrug or hybrid molecule or a pharmaceutically acceptable salt thereof, and a pharmaceutically effective carrier. Also disclosed is a composition comprising monoethanolamine or a pharmaceutically acceptable salt thereof and a pharmaceutically effective carrier, wherein the pharmaceutical composition is formulated for oral, intravenous, intraperitoneal, subcutaneous, dermal, or intranasal administration.

1 - 10 . (canceled) 
     
     
         11 . A composition consisting of:
 monoethanolamine (Etn);   water;   an acid in an amount effective to achieve a pH value between 2.0-8.0; and   a flavoring agent, taste-masking agent, sweetening agent, or combination thereof.   
     
     
         12 - 15 . (canceled) 
     
     
         16 . The composition of  claim 11 , wherein the composition has a pH value of about 5. 
     
     
         17 - 20 . (canceled) 
     
     
         21 . The composition of  claim 11 , wherein the composition has a pH value of between 4.5-5.5.